Explore comprehensive CDMO services offered by GTP Bioways, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. GTP Bioways enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: France
Description: GTP Bioways is a French biotech Contract Development and Manufacturing Organization (CDMO) acquired by Olon Group in 2024, specializing in developing and producing complex biologics, antibody-drug conjugates (ADCs), and nanodrugs from R&D to commercial stages, offering integrated services like process development, analytical testing (HCPs analysis), GMP manufacturing, and aseptic fill-and-finish, aiming to streamline drug development for biopharma clients.
